BMT MPCs definition

BMT MPCs means MPCs intended for use [***], which MPCs are packaged and labeled for use in clinical trials or for commercial purposes in accordance with the applicable Specifications and legal requirements in the Territory.
View Source
BMT MPCs means MPCs intended for use as a feeder layer in expanding or otherwise processing human hematopoietic precursor cells, which MPCs are packaged and labeled for use in clinical trials or for commercial purposes in accordance with the applicable Specifications and legal requirements in the Territory.
View Source

Examples of BMT MPCs in a sentence

  • Within thirty (30) days of expiration of the Wind-down Period, Cephalon shall, upon the request of Angioblast, transfer to Angioblast or its designee, all Excluded Products or BMT MPCs (if applicable) in its inventory at the provisional transfer price therefor (as set forth in Paragraph 2(c) of Exhibit 6.3).

  • The transfer price for all BMT MPCs, Cardiovascular Products and CNS Products supplied for Commercialization in the Territory shall be as set forth in Section 6.3 above.

  • Within thirty (30) days of expiration of the Wind-down Period, Cephalon shall, upon the request of Angioblast, transfer to Angioblast or its designee, all Products and BMT MPCs in its inventory at the provisional transfer price therefor (as set forth in Paragraph 2(c) of Exhibit 6.3).

  • Accordingly, Cephalon acknowledges that Angioblast shall have the right to package or otherwise ▇▇▇▇ such BMT MPCs, Cardiovascular Products and CNS Products in a manner that distinguishes them from those intended for Commercialization.

  • Beginning on the **** at least **** months prior to the first commercial sale of the first Product and thereafter on a **** basis, Cephalon shall provide Angioblast with a rolling written forecast of the quantities of BMT MPCs, Cardiovascular Products and CNS Products, as applicable, that Cephalon will order during the immediately following **** (“****”) and the next **** (****) succeeding **** (“****”, “****”, “****”, respectively) (each a “Rolling Forecast”).

  • Within thirty (30) days of expiration of the Wind-down Period, Cephalon shall, upon the request of Angioblast, transfer to Angioblast or its designee, all Products and BMT MPCs in its inventory at the provisional transfer price therefor (as set forth in Paragraph 2 of Exhibit 6.3).

  • Except as otherwise agreed by the Parties in the Supply Agreement, as between the Parties: (i) Cephalon shall exclusively purchase from Angioblast all requirements of the BMT MPCs, Cardiovascular Products and CNS Products (including those of its Affiliates and Marketing Partners); and (ii) Angioblast shall have the exclusive right to manufacture and have manufactured the BMT MPCs, Cardiovascular Products and CNS Products.

  • Angioblast and Cephalon shall cooperate to establish reasonable plans and procedures to avoid any shortage of supply of BMT MPCs, Cardiovascular Products and CNS Products.

  • Additionally, in order to mitigate the risk of shortage of supply the JSC may establish requirements for safety stock inventories to be maintained by the Parties and plans to extend the shelf life of BMT MPCs, Cardiovascular Products and CNS Products including stability trials to be performed by the Parties.

  • For clarity, Cephalon shall be responsible for obtaining any import or export approvals required by Regulatory Authorities in the Territory to import or export the BMT MPCs, Cardiovascular Products and CNS Products to any country or other jurisdiction within the Territory.

Related to BMT MPCs

  • Novartis shall have the meaning set forth in the Preamble.

  • Finished Product means the final packaged product intended for human consumption;

  • Product Manufacturer means the entity that assembles the component parts to manufacture the final Product;

  • Tobacco product manufacturer means an entity that after the date of enactment of this act directly (and not exclusively through any affiliate):

  • Third Party Manufacturer means (i) a Third Party whose primary business is contract manufacturing, or (ii) a Third Party who has a contractual arrangement with Licensee or with a sublicensee of Licensee that includes manufacturing of Client Product and/or Drug Product by such Third Party for Licensee or such sublicensee.